Metraipolis › archive › dc_f798f626ed4f

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany — Europe PMC PMID:40843651

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40843651
DOI
10.1111/dom.70057
License (as archived)
solo-consultazione
Archived
2026-11-10T10:10:08.326Z
SHA-256 of the archived text
027c93fdfd5857e860ed0b558a299490f966c05ca311d8c8e62814c62c1ae547
Stable URL of this page
https://metraipolis.com/documento/dc_f798f626ed4f

How to cite

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany — Europe PMC PMID:40843651 — Europe PMC (en), https://europepmc.org/article/MED/40843651 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f798f626ed4f (Metraipolis archive dc_f798f626ed4f, sha256 027c93fdfd5857e860ed0b558a299490f966c05ca311d8c8e62814c62c1ae547)
BibTeX
@misc{dcf798f626ed4f,
  title = {SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany — Europe PMC PMID:40843651},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40843651},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f798f626ed4f; sha256 027c93fdfd5857e860ed0b558a299490f966c05ca311d8c8e62814c62c1ae547},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40843651. Agents can read the archived copy with the MCP tool read_document.